Skip to main content

LISINOPRIL

NDC 68071-4858 · NuCare Pharmaceuticals,Inc.

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength5 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

68071-4858-1 — 100 TABLET in 1 BOTTLE (68071-4858-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68071-3064 — Lisinopril, 68071-3122 — Lisinopril, 68071-3123 — Lisinopril, 68071-3177 — Lisinopril and Hydrochlorothiazide, 68071-3178 — Lisinopril, 68071-3220 — Lisinopril, 68071-3409 — Lisinopril, 68071-3411 — Lisinopril, 68071-4435 — Lisinopril and Hydrochlorothiazide, 68071-4660 — Lisinopril, 68071-5036 — Lisinopril, 68071-5046 — Lisinopril, 68071-5089 — Lisinopril, 68071-5098 — Lisinopril, 68071-5143 — Lisinopril, 68180-512 — Lisinopril, 68180-513 — Lisinopril, 68180-514 — Lisinopril, 68180-515 — Lisinopril, 68180-516 — Lisinopril, +342 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels